| CYHS2500772 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs(4) | Generic Drug | 2025-02-18 | | Chengdu Shengnuo Biopharm Co Ltd | | | view |
| CYHS2402713 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs(4) | Generic Drug | 2024-08-20 | | Chengdu Shengnuo Biopharm Co Ltd | | | view |
| CXHB2400043 | 聚乙二醇化艾塞那肽注射液 | PB-119 | Injection | Chemical Drugs(1) | Supplementary Application | 2024-02-19 | | Peg BIO Co Ltd | | | view |
| CXHS2300088 | 维派那肽注射液 | PB-119 | Injection | Chemical Drugs(1) | New Drug Application | 2023-09-26 | | Peg BIO Co Ltd;Hangzhou Ausia Biological Technology Company Ltd | | | view |
| JYHZ2300036 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs | License Renew | 2023-01-19 | | AstraZeneca AB;Baxter Pharmaceutical Solutions LLC;Astrazeneca Investment (China) Co Ltd | | | view |
| JYHZ2300037 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs | License Renew | 2023-01-19 | | AstraZeneca AB;Baxter Pharmaceutical Solutions LLC;Astrazeneca Investment (China) Co Ltd | | | view |
| JYHB2200687 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs | Supplementary Application | 2022-12-31 | | AstraZeneca AB;Baxter Pharmaceutical Solutions LLC | | | view |
| JYHB2200688 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs | Supplementary Application | 2022-12-31 | | AstraZeneca AB;Baxter Pharmaceutical Solutions LLC | | | view |
| CYHS2200468 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs(4) | Generic Drug | 2022-03-21 | | Hybio Pharmaceutical Co Ltd | | | view |
| CYHS2200469 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs(4) | Generic Drug | 2022-03-21 | | Hybio Pharmaceutical Co Ltd | | | view |
| CYHS2200215 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs(4) | Generic Drug | 2022-01-28 | | Chengdu Shengnuo Biopharm Co Ltd | | | view |
| CXHL2101223 | 聚乙二醇化艾塞那肽注射液 | PB-119 | Injection | Chemical Drugs(1) | New Drug Application | 2021-06-25 | | Peg BIO Co Ltd | | | view |
| CXHL2100209 | 聚乙二醇化艾塞那肽注射液 | PB-119 | Injection | Chemical Drugs(1) | New Drug Application | 2021-03-27 | 派格生物医药（苏州）股份有限公司 | Peg BIO Co Ltd | In Review | 2021-03-26 | view |
| JYHB2001878 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs | Supplementary Application | 2020-09-25 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB;Baxter Pharmaceutical Solutions LLC | Certificate Issued | 2020-11-12 | view |
| JYHB2001879 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs | Supplementary Application | 2020-09-25 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB;Baxter Pharmaceutical Solutions LLC | Certificate Issued | 2020-11-12 | view |
| JYHB2001204 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs | Supplementary Application | 2020-07-30 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB;Baxter Pharmaceutical Solutions LLC | Filed | 2020-08-17 | view |
| JYHB2001203 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs | Supplementary Application | 2020-07-30 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB;Baxter Pharmaceutical Solutions LLC | Filed | 2020-08-17 | view |
| CXHB2000061 | 聚乙二醇化艾塞那肽注射液 | PB-119 | Injection | Chemical Drugs | Supplementary Application | 2020-06-29 | 派格生物医药（苏州）有限公司 | Peg BIO Co Ltd | In Review | 2020-06-28 | view |
| JYHB1901369 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs | Supplementary Application | 2019-11-22 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB;Baxter Pharmaceutical Solutions LLC | Certificate Issued | 2020-02-14 | view |
| JYHB1901370 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs | Supplementary Application | 2019-11-22 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB;Baxter Pharmaceutical Solutions LLC | Certificate Issued | 2020-02-14 | view |
